Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-06-Speech-3-367-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110406.29.3-367-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"The European Parliament today rejected the motion for a resolution tabled by the Committee on the Environment, Public Health and Food Safety calling for more research to be carried out before it can be claimed that docosahexaenoic acid (DHA) is a substance with beneficial properties for infants.
I regret that the resolution was not adopted without all the necessary scientific checks having been made, even though the systematic review of evidence regarding DHA and neurological development in infants published by the Cochrane Library in 2008 found that feeding term infants with milk formula enriched with DHA and other similar long-chain fatty acids has no proven benefit in terms of vision, cognition or physical growth.
Despite the doubts expressed by the Members of the Committee on the Environment, Public Health and Food Safety, the majority in Parliament has
authorised the European Food Safety Authority to declare that ‘docosahexaenoic acid contributes to the normal visual development of infants up to 12 months of age’. However, the case of the controversial Mediator drug, in particular, should lead European institutions to exercise a modicum of prudence."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples